| Krista Ruvalcaba, | |
|
550 N Hillside St, Wichita, KS 67214-4910 | |
| (316) 962-2000 | |
| Not Available |
| Full Name | Krista Ruvalcaba |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 550 N Hillside St, Wichita, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043756679 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 557459 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lawrence Memorial Hospital | Lawrence, KS | Hospital |
| University Of Kansas Health System - St Francis Campus | Topeka, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lawrence Anaesthesia Pa | 6709776172 | 24 |
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
News Archive
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has submitted a clinical study report for its Phase II/III study of azficel-T for the treatment of moderate to severe acne scars to the U.S. Food & Drug Administration (FDA).
Practicing non-pharmaceutical interventions such as hand-washing and mouth covering may help limit the transmission of the pandemic flu, but more research on these measures is critical according to a new study appearing in the May issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology, Inc.
A new indicator of variations in hemoglobin level over time is a strong predictor of the risk of death among patients receiving dialysis for end-stage renal disease (ESRD), reports a study in the December Journal of the American Society of Nephrology.
Researchers are developing new technologies that combine a laser and electric fields to manipulate fluids and tiny particles such as bacteria, viruses and DNA for a range of potential applications, from drug manufacturing to food safety.
› Verified 8 days ago
| Entity Name | Lawrence Anaesthesia Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487618229 PECOS PAC ID: 6709776172 Enrollment ID: O20040318000886 |
News Archive
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has submitted a clinical study report for its Phase II/III study of azficel-T for the treatment of moderate to severe acne scars to the U.S. Food & Drug Administration (FDA).
Practicing non-pharmaceutical interventions such as hand-washing and mouth covering may help limit the transmission of the pandemic flu, but more research on these measures is critical according to a new study appearing in the May issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology, Inc.
A new indicator of variations in hemoglobin level over time is a strong predictor of the risk of death among patients receiving dialysis for end-stage renal disease (ESRD), reports a study in the December Journal of the American Society of Nephrology.
Researchers are developing new technologies that combine a laser and electric fields to manipulate fluids and tiny particles such as bacteria, viruses and DNA for a range of potential applications, from drug manufacturing to food safety.
› Verified 8 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has submitted a clinical study report for its Phase II/III study of azficel-T for the treatment of moderate to severe acne scars to the U.S. Food & Drug Administration (FDA).
Practicing non-pharmaceutical interventions such as hand-washing and mouth covering may help limit the transmission of the pandemic flu, but more research on these measures is critical according to a new study appearing in the May issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology, Inc.
A new indicator of variations in hemoglobin level over time is a strong predictor of the risk of death among patients receiving dialysis for end-stage renal disease (ESRD), reports a study in the December Journal of the American Society of Nephrology.
Researchers are developing new technologies that combine a laser and electric fields to manipulate fluids and tiny particles such as bacteria, viruses and DNA for a range of potential applications, from drug manufacturing to food safety.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Krista Ruvalcaba, 3450 N Rock Rd, Suite 208, Wichita, KS 67226-1327 Ph: (316) 789-8444 | Krista Ruvalcaba, 550 N Hillside St, Wichita, KS 67214-4910 Ph: (316) 962-2000 |
News Archive
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has submitted a clinical study report for its Phase II/III study of azficel-T for the treatment of moderate to severe acne scars to the U.S. Food & Drug Administration (FDA).
Practicing non-pharmaceutical interventions such as hand-washing and mouth covering may help limit the transmission of the pandemic flu, but more research on these measures is critical according to a new study appearing in the May issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology, Inc.
A new indicator of variations in hemoglobin level over time is a strong predictor of the risk of death among patients receiving dialysis for end-stage renal disease (ESRD), reports a study in the December Journal of the American Society of Nephrology.
Researchers are developing new technologies that combine a laser and electric fields to manipulate fluids and tiny particles such as bacteria, viruses and DNA for a range of potential applications, from drug manufacturing to food safety.
› Verified 8 days ago
Jaysa L Nichols, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8080 E Central Ave, Suite 250, Wichita, KS 67206 Phone: 316-686-7327 Fax: 316-858-1556 | |
George Findley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8080 E Central Ave Ste 250, Wichita, KS 67206 Phone: 316-461-4497 Fax: 316-686-1557 | |
Jill C Gallagher, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8330 E Overbrook St, Wichita, KS 67206 Phone: 316-644-1193 | |
Janet L Miller, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3450 N Rock Rd Ste 208, Wichita, KS 67226 Phone: 316-685-6091 | |
Seth Claassen, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8080 E Central Ave Ste 250, Wichita, KS 67206 Phone: 316-686-7327 Fax: 316-686-1557 | |
Wade Frederick Winter, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 929 N Saint Francis Ave, Wichita, KS 67214 Phone: 316-268-5000 Fax: 316-291-4272 | |
Mr. Brian Lee Moore, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6615 Briarwood Cir, Wichita, KS 67212 Phone: 316-729-4474 Fax: 316-729-4474 |